BioRestorative Therapies (BRTX) Return on Sales (2012 - 2025)
BioRestorative Therapies' (BRTX) quarterly Return on Sales came in at 13.47% in Q4 2025, down 1284.0% YoY from 1.14% in Q4 2024, and down 328.67% on a QoQ basis from 3.14% in Q3 2025.
BioRestorative Therapies (BRTX) Return on Sales (2012 - 2025) Analysis & Trends
BioRestorative Therapies (BRTX) has 14 years of Return on Sales data on file, last reported at 13.47% in Q4 2025.
- Quarterly Return on Sales fell 1284.0% year-over-year to 13.47% in Q4 2025, while the trailing twelve-month figure through Dec 2025 was 1.09% (down 80.0% YoY) and the FY2025 annual result came in at 1.06%, down 4.0% from the prior year.
- Return on Sales eased to 13.47% in Q4 2025, from 3.14% in the prior quarter.
- In the past five years, Return on Sales ranged from a high of 0.1% in Q3 2024 to a low of 13.47% in Q4 2025.
- A 5-year average of 3.44% and a median of 1.78% in 2023 frame the typical range for Return on Sales.
- Annual changes were most pronounced in 2023 — Return on Sales soared 1107 bps — and 2025, when it tumbled 1284 bps.
- Tracing BRTX's Return on Sales over 5 years: stood at 8.1% in 2021, then tumbled by 58 bps to 12.76% in 2022, then soared by 87 bps to 1.69% in 2023, then jumped by 63 bps to 0.63% in 2024, then sank by 2034 bps to 13.47% in 2025.
- The last three Return on Sales figures came in at 13.47% (Q4 2025), 3.14% (Q3 2025), and 0.12% (Q2 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROS (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn | 0.00% |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn | 0.00% |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn | 0.00% |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn | -0.05% |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn | 0.00% |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn | 0.00% |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn | 0.00% |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn | 0.00% |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - | 0.00% |
| 10 | BioRestorative Therapies | 1.94 Mn | -1.02 Mn | 17,964.00 | -1.95% |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -13.47% |
| Sep 30, 2025 | -3.14% |
| Jun 30, 2025 | -0.12% |
| Mar 31, 2025 | -2.15% |
| Dec 31, 2024 | -0.63% |
| Sep 30, 2024 | -0.10% |
| Jun 30, 2024 | -0.28% |
| Mar 31, 2024 | -1.21% |
| Dec 31, 2023 | -1.69% |
| Sep 30, 2023 | -1.02% |
| Jun 30, 2023 | -0.49% |
| Mar 31, 2023 | -1.86% |
| Dec 31, 2022 | -12.76% |
| Sep 30, 2022 | -1.61% |
| Jun 30, 2022 | -0.66% |
| Mar 31, 2022 | -3.18% |
| Dec 31, 2021 | -8.10% |
| Sep 30, 2021 | -5.23% |
| Jun 30, 2021 | -2.76% |
| Mar 31, 2021 | -8.39% |